Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma.
Ontology highlight
ABSTRACT: Immunotherapies blocking negative immune checkpoints are now approved for the treatment of a growing number of cancers. However, even in metastatic melanoma, where sustained responses are observed, a significant number of patients still do not respond or display resistance. Increasing evidence indicates that non-genetic cancer cell-intrinsic alterations play a key role in resistance to therapies and immune evasion. Cancer cell plasticity, mainly associated with the epithelial-to-mesenchymal transition in carcinoma, relies on transcriptional, epigenetic or translational reprogramming. In melanoma, an EMT-like dedifferentiation process is characterized by the acquisition of invasive or neural crest stem cell-like features. Herein, we discuss recent findings on the specific roles of phenotypi
SUBMITTER: Benboubker V
PROVIDER: S-EPMC9012258 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA